I-Mab Profit Margin 2020-2021 | IMAB
Current and historical gross margin, operating margin and net profit margin for I-Mab (IMAB) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. I-Mab net profit margin as of June 30, 2021 is 0%.
|I-Mab Annual Profit Margins
|I-Mab Quarterly Profit Margins
||Medical - Biomedical and Genetics
I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.